Transcriptional regulation of the murine Elf3 gene in embryonal carcinoma cells and their differentiated counterparts: Requirement for a novel upstream regulatory region

Gene

Volumn 340, Issue 1, 2004, Pages 123-131

  Hou, Jingwen ^a   Wilder, Phillip J ^a   Bernadt, Cory T ^a,b   Boer, Brian ^a,b   Neve, Richard M ^c   Rizzino, Angie ^a,b,d  

^a Eppley Inst Res Cancer All D   (United States)

^b Dept Pathol Microbiol Univ N ^*  (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^d NEBRASKA MEDICAL CENTER   (United States)

Author keywords

5 RACE; Differentiation; Distal enhancer; EC; electrophoretic mobility shift assay; embryonal carcinoma; EMSA; ERT; ESE1; ESX; Ets proteins; Gene regulation; Jen; RA; rapid amplification of cDNA ends; retinoic acid; T R II; type II TGF receptor

Indexed keywords

ARTICLE; CARCINOMA CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE MAPPING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; UPREGULATION;

5' FLANKING REGION; ANIMALS; BASE SEQUENCE; CARCINOMA, EMBRYONAL; CELL DIFFERENTIATION; CELL LINE, TUMOR; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; LUCIFERASES; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC; TRANSFECTION;

MURINAE;

EID: 5444256118     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2004.06.007     Document Type: Article

References (24)

1. Adamson E.D., Graham C.F. Loss of tumorigenicity and gain of differentiated function by embryonal carcinoma cell. Results Probl. Cell Differ. 11:1980;290-297
2. Bucher P. Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J. Mol. Biol. 212:1990;563-578
3. Chang C.H., Scott G.K., Kuo W.L., Xiong X., Suzdaltseva Y., Park J.W., Sayre P., Erny K., Collins C., Gray J.W., Benz C.C. ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis. Oncogene. 14:1997;1617-1622
4. Chang J., Lee C., Hahm K.B., Yi Y., Choi S.G., Kim S.J. Over-expression of ERT(ESX/ESE-1/ELF3), an ets-related transcription factor, induces endogenous TGF-beta type II receptor expression and restores the TGF-beta signaling pathway in Hs578t human breast cancer cells. Oncogene. 19:2000;151-154
5. Choi S.G., Yi Y., Kim Y.S., Kato M., Chang J., Chung H.W., Hahm K.B., Yang H.K., Rhee H.H., Bang Y.J., Kim S.J. A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates expression of the transforming growth factor-beta type II receptor. J. Biol. Chem. 273:1998;110-117
6. Dittmer J., Nordheim A. Ets transcription factors and human disease. Biochim. Biophys. Acta. 1377:1998;F1-F11
7. Grall F., Gu X., Tan L., Cho J.Y., Inan M.S., Pettit A.R., Thamrongsak U., Choy B.K., Manning C., Akbarali Y., Zerbini L., Rudders S., Goldring S.R., Gravallese E.M., Oettgen P., Goldring M.B., Libermann T.A. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1. Arthritis Rheum. 48:2003;1249-1260
8. Isola J.J., Kallioniemi O.P., Chu L.W., Fuqua S.A., Hilsenbeck S.G., Osborne C.K., Waldman F.M. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am. J. Pathol. 147:1995;905-911
9. Kim J.H., Wilder P.J., Hou J., Nowling T., Rizzino A. Activation of the murine type II transforming growth factor-beta receptor gene: up-regulation and function of the transcription factor Elf-3/Ert/Esx/Ese-1. J. Biol. Chem. 277:2002;17520-17530
10. Kopp J.L., Wilder P.J., Desler M., Kim J.H., Hou J., Nowling T., Rizzino A. Unique and selective effects of five Ets family members, Elf3, Ets1, Ets2, PEA3 and PU.1, on the promoter of the type II TGF-beta receptor gene. J. Biol. Chem. 279:2004;19407-19420
11. Laudet V., Hanni C., Stehelin D., Duterque-Coquillaud M. Molecular phylogeny of the ETS gene family. Oncogene. 18:1999;1351-1359
12. Lee H.J., Chang J.H., Kim Y.S., Kim S.J., Yang H.K. Effect of ets-related transcription factor (ERT) on transforming growth factor (TGF)-beta type II receptor gene expression in human cancer cell lines. J. Exp. Clin. Cancer Res. 22:2003;477-480
13. Mantovani R., Li X.Y., Pessara U., Hooft v.H., Benoist C., Mathis D. Dominant negative analogs of NF-YA. J. Biol. Chem. 269:1994;20340-20346
14. Morrisey E.E., Ip H.S., Lu M.M., Parmacek M.S. GATA-6: a zinc finger transcription factor that is expressed in multiple cell lineages derived from lateral mesoderm. Dev. Biol. 177:1996;309-322
15. Murakami A., Thurlow J., Dickson C. Retinoic acid-regulated expression of fibroblast growth factor 3 requires the interaction between a novel transcription factor and GATA-4. J. Biol. Chem. 274:1999;17242-17248
16. Neve R., Chang C.H., Scott G.K., Wong A., Friis R.R., Hynes N.E., Benz C.C. The epithelium-specific ets transcription factor ESX is associated with mammary gland development and involution. FASEB J. 12:1998;1541-1550
17. Ng A.Y., Waring P., Ristevski S., Wang C., Wilson T., Pritchard M., Hertzog P., Kola I. Inactivation of the transcription factor Elf3 in mice results in dysmorphogenesis and altered differentiation of intestinal epithelium. Gastroenterology. 122:2002;1455-1466
18. Nowling T., Bernadt C., Johnson L., Desler M., Rizzino A. The co-activator p300 associates physically with and can mediate the action of the distal enhancer of the FGF-4 gene. J. Biol. Chem. 278:2003;13696-13705
19. Oettgen P., Alani R.M., Barcinski M.A., Brown L., Akbarali Y., Boltax J., Kunsch C., Munger K., Libermann T.A. Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family. Mol. Cell. Biol. 17:1997;4419-4433
20. Oettgen P., Barcinski M., Boltax J., Stolt P., Akbarali Y., Libermann T.A. Genomic organization of the human ELF3 (ESE-1/ESX) gene, a member of the Ets transcription factor family, and identification of a functional promoter. Genomics. 55:1999;358-362
21. Park S.H., Kim Y.S., Park B.K., Hougaard S., Kim S.J. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: implication for the loss of TGF-beta type II receptor expression. Oncogene. 20:2001;1235-1245
22. Reddy S.P., Vuong H., Adiseshaiah P. Interplay between proximal and distal promoter elements is required for squamous differentiation marker induction in the bronchial epithelium: role for ESE-1, Sp1, and AP-1 proteins. J. Biol. Chem. 278:2003;21378-21387
23. Rudders S., Gaspar J., Madore R., Voland C., Grall F., Patel A., Pellacani A., Perrella M.A., Libermann T.A., Oettgen P. ESE-1 is a novel transcriptional mediator of inflammation that interacts with NF-kappa B to regulate the inducible nitric-oxide synthase gene. J. Biol. Chem. 276:2001;3302-3309
24. Tymms M.J., Ng A.Y., Thomas R.S., Schutte B.C., Zhou J., Eyre H.J., Sutherland G.R., Seth A., Rosenberg M., Papas T., Debouck C., Kola I. A novel epithelial-expressed ETS gene, ELF3: human and murine cDNA sequences, murine genomic organization, human mapping to 1q32.2 and expression in tissues and cancer. Oncogene. 15:1997;2449-2462